Innate Pharma S.A. ( IPHYF) - Stock Earnings
IPHYF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -25.2 million USD | 5.7 million USD |
| 2025Q4 | -32.7 million USD | 1.3 million USD |
| 2026Q1 | -31.9 million USD | 1.3 million USD |
| 2026Q2 Est. | — | — |
IPHYF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.4 million USD | 68.1 million USD |
| 2024 | -51.5 million USD | 13.1 million USD |
| 2025 | -57.7 million USD | 3.3 million USD |
| 2026 Est. | — | — |
IPHYF
Price: $1.65
52 week price:
Earnings Per Share: -0.64 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 154.9 million